2014-01-30 05:13:02 - Global Stem Cell Anticancer Therapeutics Market 2012-2016 - a new market research report on companiesandmarkets.com
The Global Stem Anticancer Therapeutics market is to grow at a CAGR of 11.48 percent over the period 2012-2016. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a challenge to the growth of this market.
One of the main trends witnessed in the Global Stem Cell Anticancer Therapeutics market is the increase in industry activities. Cancer therapy apart from usual radiotherapy has entered into new era of stem cell therapy. Research is going on to recognize and isolate cancer stem cells with those of normal stem cells by using
cell surface antigen markers. More intricate research work is needed to carry out reveal signalling pathways and functioning of different genes in process of carcinogenesis during cancer stem cell differentiation. This would help in development of new therapies which would help in elimination of eventual disease and recurrence. This trend is expected to have a strong impact on the growth of the market..
One of the main factors driving the market is the significant increase in the drug pipeline targeting cancer stem cells. These cells have the capacity to divide and give rise to new cancer stem cells through a process called self-renewal and have the ability to change into the other cells that form the bulk of the tumour.
One of the main challenges is the lack of awareness in developing countries. Most of the patients in developing countries such as India and China are not fully aware of the recent developments in stem cell products and therapies.
The key vendors dominating this space include Celgene Corp., Curis Inc., Exelixis Inc., Gamida Cell Ltd., Lonza Group, Merck & Co. Inc., OncoMed Pharmaceuticals Inc., Pfizer Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., and Verastem Inc.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.